th World Congress on Breast Cancer · Breast-Sparing Surgery Symptoms of Breast Cancer in Men...

April 25-26, 2019London, UK

Breast Cancer9th World Congress on

S C I E N T I F I C P R O G R A M

conferenceseries.com

SCIENTIFIC PROGRAM

Thursday, 25th April DAY 1Thursday, 25th April

08:30-09:00 Registrations

09:00-09:30 Introduction

09:30-09:50 COFFEE BREAK

09:50-11:50 Meeting Hall 01

KEYNOTE LECTURES

MEETING HALL 01 MEETING HALL 02

11:50-13:10 Talks On: Breast Cancer Therapy , Prevention and Medicine

Talks On: Screening, Detecting and Diagnosing Breast Cancer

Chemotherapy, Hypnotherapy, Radiation Therapy Breast Magnetic Resonance Imaging

Early & Advanced Breast Cancer Systemic Therapy Mammography

Breast Reconstruction Therapy Clinical Breast Exam and Breast self-exam

Treatment of Breast Cancer During Pregnancy Breast Ultrasound

Pros and Cons of Breast Cancer Screening

13:10-13:15 GROUP PHOTO

13:15-14:00 LUNCH BREAK


14:00-16:00 Talks On: Surgery Choices for Breast Cancer Talks On: Male Breast Cancer

Breast-Sparing Surgery Symptoms of Breast Cancer in Men

Breast-Conserving Surgery or Mastectomy Risk Factors for Breast Cancer in Men

Lymph Node Surgery Familial Predisposition

Breast Reconstruction Surgery Staging and Diagnosis

Tissue Flap Surgery Protein Biochemistry

Mass spectrometry techniques Protein Interaction


MEETING HALL 01 (16:20-17:00) MEETING HALL 01 (17:00-18:00)

Young Researchers in Breast Cancer Workshop

Visit: https://breastcancer.conferenceseries.com/

SCIENTIFIC PROGRAM

Friday, 26th April DAY 2Friday, 26th April

09:00-10:30 Meeting Hall 01

KEYNOTE LECTURES



10:50-12:50 Talks On: Breast Cancer Nursing

Talks On: Immunology and Breast Cancer

Professional and Ethical Understanding of Patients Immune Response

Assessment and Management of Patients Breast Carcinoma and Immunity

Multidisciplinary Care Immune Reaction towards Breast

Values and Attitudes in relation to the care Tumor Antigens

Psychological Support Immunotherapy

Molecular diagnostics for infectious disease Self Antigens

12:50-13:35 LUNCH BREAK


13:35-15:55 Talks On: Alternative and Complementary Medicine

Talks On: Current and Future State

Conventional and Alternative Medicine Radiotherapy and Novel Agents in Combination

Spirituality, Religion and Complementary Medicine

Techniques to Lower the side effects of Radiotherapy

Meditation, Massage, Acupuncture and Herbs Challenges

Optimization of Combined Treatment Surgical Treatment

Intake of Supplements Screening Methods


MEETING HALL 01 (16:15-17:00) MEETING HALL 01 (17:00-18:00)

Poster Presentations Workshop


9th World Congress

on Breast Cancer

April 25-26, 2019 | London, UK

AGENDA

SP

EAK

ER S

LOT

S A

VA

ILA

BLE

Dr. Geert C. Mudde received a Ph.D. in immunology from the University of

Utrecht in 1985 and started his international professional career at the Swiss Institute for Asthma and Allergy Research in Davos in 1989. In 1992 he joined

the pharmaceutical/biotech industry, where he held several senior

management positions at the Novartis Research Institute in Vienna, Austria, the Parke Davis Research Institute in Fresnes, France, Ingenium

Pharmaceuticals, Martinsried, Germany, and at igeneon AG, Vienna, Austria.

Finally, in 2006, while joining Baxter BioScience in Vienna as interim manager, Dr. Mudde co-founded the biotech company f-star Biotechnology,

where he served as “Chief Scientific Officer” from 2007 to 2009.

Dr Geert C. Mudde

OncoQR ML GmbH,

Austria

Dr. Kim O’Neill completed his PhD at the University of Ulster in the Biomedical Sciences Research Center. He was recruited to Brigham Young University, in Provo

Utah in 1992. He has published over 140 peer reviewed papers, and presented his

research at numerous international meetings. Dr. O’Neill is a member of the American Association for Cancer Research (AACR), and currently serves on the

AACR Science Education committee.

Dr. Kim O’Neill

Brigham Young

University

USA

Dr. Mark graduated Phi Beta Kappa and Summa Cum Laude from Yale University. He received his Medical Degree from UCLA and also completed his residency in

Radiation Oncology at UCLA. He has published or presented more than 250 papers

or abstracts at peer-reviewed national and international meetings. Baylor Scott & White

Medical Center, USA

SP

EAK

ER S

LOT

S A

VA

ILA

BLE

Prof P.A. Cohen is Full Professor in Molecular Biology and Biotechnology in the

Faculty of Pharmacy of the University of Lyon, France since 2005. She is also

Principal Investigator and manages a team in the CRCL Cancer Research Center

of Lyon CRCL UMR INSERM 1052-CNRS 5286, France. She got a degree in

Pharmacy (1991), a PhD in Biomedical Sciences (1995, Univ. Montpellier,

France). She was Post-doctoral fellow in the Cancer Research Campaign

Laboratories, University of Dundee, Scotland, U.K. (1996-98, Advisor: Sir Prof.

D.P. Lane, F.R.S.). She got several honors such as Exceptional Class Professor

Distinction and her research work has been awarded by many prizes. She is also

committed in several national and international education programs and is

frequently requested as external scientific referee for international scientific

journals or committees.

Centre de Recherche en

Cancérologie de Lyon,

France

Dr.Abouelnagah born in Alexandria, Egypt and did his Medical Studies at Alexandria University. He had Master Degree in Colorectal surgery 1993, FRCS

Glasgow and FRCS Edinburgh 1999, Diploma in Laparoscopy from Europian

Surgical Institute, Germany, August 2000, MD surgical oncology from Alexandria Univerisity, July 2003, MBA in hospital management:, February 2010

and lastly FRCS London, Sep 2010. In 1995 he worked as a senior registrar at

Jeddah, Saudi Arabia, in 1996 he became assistant lecturer at Alexandria

University.

Alexandria University

Egypt

Hend has completed her MSc in nursing at the age of 31 years from the

Royal College of Surgeons in Ireland with a first class honor degree. She

has more than 8 years experience in the field of nursing and is the charge

nurse of oncology OPD in SKSH which is one of the well known hospitals

offering oncology care in the UAE. She has reported her Msc dissertation in

two international conferences.

SP

EAK

ER S

LOT

S A

VA

ILA

BLE

Dr. Tanay N. Shah is a surgical oncologist. He has pursued his academic

qualifications from several reputed institutes.MBBS from Govt. Medical College,

Baroda (M.S. university), India M.S. in General Surgery from Govt. Medical

College, Baroda (M.S. university), India FMAS(Fellowship in Minimal Access

Surgery) from SMIMER, Surat, India . DNB – Surgical Oncology from Bhagwan

Mahaveer Cancer Hospital & Research Center, Jaipur, India

Bhagwan Mahaveer

Cancer Hospital &

Research Centre,

India

The nurse has her expertise in evaluation and passion in improving the health and

wellbeing.She has built this model after years of experience in research, evaluation,

teaching and administration both in hospital and education institutions.

Medical oncologist specialist in systemic treatment (chemotherapy, hormone

therapy, white therapy, immunotherapy) for cancer. The treatment is totally

individualized and depends on multiple factors. During the consultation, imaging,

laboratory and pathology studies are evaluated to provide the best option.

Delgado-Salgado

Daniela, Mexico

SP

EAK

ER S

LOT

S A

VA

ILA

BLE

Dr.ABOUELNAGAH born in Alexandria, Egypt and did his Medical Studies at

Alexandria University. He had Master Degree in Colorectal surgery 1993, FRCS

Glasgow and FRCS Edinburgh 1999, Diploma in Laparoscopy from Europian

Surgical Institute, Germany, August 2000, MD surgical oncology from

Alexandria Univerisity, July 2003, MBA in hospital management:, February 2010 and

lastly FRCS London, Sep 2010. In 1995 he worked as a senior registrar at Jeddah,

Saudi Arabia, in 1996 he became assistant lecturer at Alexandria University Surgical Alexandria University

Egypt

Styliani Parpoudi completed her MSc in 2014 from Democritus University of Thrace

and she is currently in the process of submitting her doctoral dissertation from

Aristotle University of Thessaloniki. She completed her specialty training in General

Surgery in 2017 at the 4th University Department of General Surgery of Aristotle

University of Thessaloniki and, for the last 2 years, she is working as a consultant in

the Surgical Oncology Breast Unit of ‘Theagenio’ Cancer Hospital in Thessaloniki.

She has published 11 papers in reputed national and international magazines and she

has participated as a speaker in 12 national and international congresses.

In 2006 she was admitted into Akim-oda community health nursing training

school and completed successfully. She was posted to ST John of God hospital in

the Tano north district Brong-Ahafo in 2009. She worked as a community health

nurse for three years. In 2014 She completed midwifery nursing training from

Goaso. She was then reposted to another district thus Asutifi north and at the

district was send to work at krakyekrom CHPS compound as a midwife.

SP

EAK

ER S

LOT

S A

VA

ILA

BLE

Manal Malki is a Masters student at King Saud University.She has undertaken this

research Project under the supervision of well known Dr.Samina Hyder Haq. Her

studies are of great value and importance for the scientific community as her

conclusive Molecular Biology Experements revealed a direct relationship of the gene

expression of Bcl-2/Bax ratio in the etiology of Breast cancer and possibility of using

Melatonin and Vitamin D3 along with Timoxifen could greatly increase the efficacy

and better strategy to treat Breast Cancer.

Nora Saad Alkeraishan is a Masters students at King Saud University, Riyadh Saudi

Arabia.She undertook this Research Project under direct supervision of well known

Scientist Dr. Samina Hyder Haq. Her intersting studies on the effect of Melatonin and

Vitamin D3 on Breast Cancer Cell line MCF-7 revealed that Melatonin could

significantly upregulate p53 gene expression in cultured cells and observed no direct

relatioship of Vitamin D3 in upregulating p53 gene expression. Currently she is

involved in genotyping the p53 to detect mutations present in the gene itself.

Wakeel Adelani Tijani is a Professor of Nursing, Public Health specialty. He has over

20 year working experience. He has worked as bed-side nurse, tutor at basic school of

nursing and lecturer departments of nursing in universities. He started his lectureship

career at Ladoke Akintola University of Technology Ogbomoso in 2003 as an

Assistant Lecturer, and rose steadily to full Professor of Nursing at Bayero University

Kano in 2015. He has occupied many leadership posts in nursing. He has over 50

publications to his credit. He has attended many conferences, local and international,

where he presented papers on health issues.

SP

EAK

ER S

LOT

S A

VA

ILA

BLE

Adejumoke SANUSI is a registered nurse, registered midwife, registered public

health nurse. She is a BNSc and MSc (Nursing science) graduate. She has worked in

the hoapital settings for some years before joining the university system four (4) years

ago. She has twelve (12) published articles. She has attended national and

international conferences.

Petra El Hajj has completed his PhD on 2015 from Lebanese university and

Universite Libre de Bruxelles, where she has published 4 articles on TYRP1

expression and regulation in melanoma, among them two in the “British journal of

cancer”. Nowadays, she is a lecturer at Lebanese University, faculty of sciences, and a

researcher in the same institution in the field of triple negative breast cancer in female

Lebanese patients.

Prakash Kinthada is a Professor in Chemistry at Sri Vidyanikethan Engineering

college, JNTU University in Ananthapur, A. Rangam Peta, Tirupathi, India.

SP

EAK

ER S

LOT

S A

VA

ILA

BLE

Ms. Divya Bakshi is currently pursuing her Ph.D. from Shri Mata Vaishno Devi

University, India, and is currently in her 4rth year of Ph.D. work.

Nora Klöting is from University of Leipzig , Specialisation is IFB AdiposityDiseases.

Wassil Nowicky Nowicky Pharma, Austria

Peter Onneken Institute of Diet and Health, Germany

Yoko Matsumoto Sojo University, Japan

Manuela Lacerda IPATIMUP, Portugal

Imrana Masroor Aga Khan University Hospital, Pakistan

Maryam Mansoori Iran University of Medical Sciences, Iran

Olaf G Wilhelm Therawis Diagnostics GmbH, Germany

Ratna Parikh Breach Candy Hospital, India

Alicia González González Cantabria University, Spain

Javier Menéndez Menéndez University of Cantabria, Spain

Maria Inês Branco Centro Hospitalar Vila Nova de Gaia/Espinho, Portugal

Peter Sandbichler Hospital St.Vinzenz, Austria

Vuka V Katic Human Policlinic,Serbia

Stefan Glück Celgene Corporation,USA

Hiltrud Brauch Dr. Margarete Fischer-Bosch-Institute of Clinical Pharmacology, Germany

Baris Cankaya University Pendik Training Hospital, Turkey

Gul Cankaya University Pendik Training Hospital, Turkey

Jack Sariego Aria-Jefferson Health System, PA USA

Ashutosh Kothari Guys Hospital,UK

Hong Zhang University of Texas-M D Anderson Cancer Center, USA

Yun Gong MD Anderson Cancer Center, USA

Hongying He The University of Texas Medical School at Houston,USA

Jill Hervik Vestfold Hospital Trust, Norway

Valerijus Ostapenko

PAST AFFILIATESPA

ST A

FFIL

IATE

S


National Cancer Institute,Lithuania

Ashmitha Srinivasan MD Anderson Cancer Center, TX USA

Carole Verhoeven Pantarhei Bioscience,The Netherlands

Jana Slobodníková Alexander Dubček University in Trenčín, Slovak republik

Marike Gabrielson Karolinska Institutet,Sweden

Sakina E. Elto Meharry Medical College,USA

Steven M. Hill Tulane University, USA

Lloyd Jenkins Budwig Center, Spain

Sarah Spiegel Virginia Commonwealth University, USA

Sheldon Milstien Virginia Commonwealth University, USA

Cohen-Armon Tel-Aviv University,Turkey

Anne Ryhänen University of Turku, Finland

Shikai Wu Affiliated Hospital of Academy of Military Medical Sciences,China

Hale AYDIN

Dr Abdurrahman Yurtaslan Ankara Oncology Training and Research Hospital,Turkey

Guan Chen Medical College of Wisconsin, USA

Kim Jaffee Wayne State University, USA

Lidija Covic Tufts Medical Center, USA

Shahla Masood Medical Director, UF Health Breast Center, USA

M.P. van den Tol University Medical Center De Boelelaan , The Nederlands

Gaiane M. Rauch UT MD Anderson Cancer Center, USA

Michael Thompson University of Wroclaw, Canada

Emmanuelle Charafe-Jauffret University of Mediterranée, France

Daphne Gschwantler-Kaulich Medical University of Vienna, Austria

PAST AFFILIATESPA

ST A

FFIL

IATE

S


PAST AFFILIATES Jun Yang St Jude Children’s Research Hospital, USA

Antonio Carlos Wolff The Johns Hopkins University , USA

Linda A. deGraffenried The University of Texas at Austin, USA

Chang Gong Sun Yat-Sen University, China

Marco Bernini Careggi University Hospital,Florence, Italy

Ragheed Al-Mufti The West of London Breast Cancer Network, UK

Maude Hébert University of Quebec in Trois-Rivieres, Canada

Giorgio Berna Director Regional Hospital of Treviso, Italy

Prof. C C Busby Professor & Director Environmental Research SIA, United Kingdom

Fraid Meybodi Breast and Endocrine Surgeon Westmead Hospital , Australia

Peter Weightman Professor University of Liverpool, United Kingdom

Amila Orucevic Associate Professor University of Tennessee Medical Center , USA

Kiven Erique Lukong

Associate Professor University of Saskatchewan, Canada

San Ming Wang Associate Professor University of Nebraska, USA

Federico Cattin Breast Surgeon Sterzing General hospital, Italy

Matthew Curzon Pathology Resident University of Tennessee Medical Center , USA

Raj Kumar Professor The Commonwealth Medical College, USA

Philippa Darbre Associate Professor University of Reading, United Kingdom

Anne Marie Lunde Husebø Assistant Professor University of Stavanger, Norway

Syeda Zakia Hossain Senior Lecturer The University of Sydney, Australia

Susan J Done Associate Professor University of Toronto, Canada

PAST

AFF

ILIA

TES


PAST AFFILIATESIgor Buchwalow Professor University of Muenster, Germany

Thomas Kieber-Emmons Professor University of Arkansas for Medical, Scien, USA

Stefan B. Eichmüller Professor German Cancer Research Center, Germany

Guldeniz Karadeniz Cakmak Associate Professor Bulent Ecevit University, Turkey

Diptendra K Sarkar Professor IPGMER, India

Nicolae Bacalbasa Professor Fundeni Clinical Institute, Romania

Werner Boecker Professor University of Muenster, Germany

Mihaela Lorger Group Leader University of Leeds, United Kingdom

Tibor tot Associate Professor University of Uppsala, Sweden

John Bell Professor of Surgery University of Tennessee Medical Center, USA

Aysegul A. Sahin Professor & Director The University of Texas, USA

Graham Ross Roche Products Limited, Herts, United Kingdom

Vicente Marco Director Hospital Quirón Barcelona, Spain

Sidharth Sahni Breast surgeon Indraprastha Apollo Hospital, India

Lei Huo Associate Professor MD Anderson Cancer Center, USA

Yvonne Paterson Professor University of Pennsylvania, USA

Daniel Snyder Pathology Resident University of Tennessee Medical Center , USA

Heather Gage Pathology Resident University of Tennessee Medical Center, USA

PAST

AFF

ILIA

TES


London Attractions

Lond

on Eye

Big Ben

British

Mus

eum

Tower

Brid

ge

The

Shar

d

War

ner B

ros.

Stud

io

Tower

of L

ondo

n

Mad

ame

Tuss

auds

Sea

Life

Lond

on

Glimpses ofBreast Cancer Conferences


conferenceseries.com1614th Conference

M a y 1 0 - 1 1 , 2 0 1 8 | F r a n k f u r t , G e r m a n y

Scientific Program

UK: Conference Series llc LTD47 Churchfield Road, London, W3 6AY

Toll Free: +0-800-014-8923

7th World Congress on Breast Cancer

RegistrationsDay 1 May 10, 2018

Keynote ForumIntroductionTitle: The antiangiogenic properties of NSC-631570 (Ukrain) on breast cancerWassil Nowicky, Nowicky Pharma/ Ukrainian Anti-Cancer Institute, AustriaTitle: Endocrine treatment of breast cancer: current concepts to predict and prevent relapseHiltrud Brauch, Dr. Margarete Fischer-Bosch-Institute of Clinical Pharmacology, GermanyTitle: Title:Immuno-Oncology in Breast cancer: early promise?Stefan Glück, Celgene Corporation, USA

Group Photo

Networking and Refreshments Break FoyerSessions: Screening, Detecting and Diagnosing Breast Cancer | Breast Cancer Therpy , Prevention and MedicineSession Chair: Wassil Nowicky, Nowicky Pharma/ Ukrainian Anti-Cancer Institute, Austria Session Co-Chair: Ratna Parikh, Breach Candy Hospital, IndiaTitle: Concerning the changing of diagnostic approach, guidelines, role and importance on decision of the different medical specialties involved ( in the last 30 years) in the setting of a screening and treatment reference hospital Manuela Lacerda, IPATIMUP, PortugalTitle: Melatonin enhances chemosensitivity of human endothelial and breast cancer cells by regulating genes involved in angiogenesisAlicia González González, University of Cantabria, Spian

Lunch Break @ Rastaurant palate friendTitle: Effects of melatonin on chemotherapy treatments in gene expression and proteomics of human breast cancer Javier Menéndez Menéndez, University of Cantabria, SpianTitle: Blocks for relieving pain associated with breast surgeryBaris Cankaya, Marmara University Pendik Training Hospital, TurkeyTitle: The breast-q in perioperative period for breast conserving surgery: how patient reported outcome measures contribute to health related quality of life Gul Cankaya, Marmara University Pendik Training Hospital, Istanbul/ TurkeyTitle: Experiences in organisation of Breast cancer facilities in rural IndiaRatna Parikh, Breach Candy Hospital , Mumbai, IndiaTitle: Giant inflammatory myofibroblastic tumor of the breast case report and review of literatureVuka V Katic, Human Policlinic, Serbia

Networking and Refreshments Break @ FoyerTitle: Accuracy of the specimen radiography in the breast-conservation surgeryImrana Masroor, Aga Khan University Hospital Karachi, PakistanTitle: Adjuvant endocrine monotherapy for postmenopausal early breast cancer patients with hormone-receptor positive: a systemic review and network meta-analysisHaitian Zhang, First Affiliated Hospital of Guangxi Medical University, ChinaTitle : Nutrition and breast cancer rates in high and low happiness countriesLyudmila Radkevich, Russian Academy of Sciences, Moscow, Russia

Panel Discussion Day 2 May 11, 2018

Conference Hall-Taunus

Opening Ceremonyconferenceseries.com

Conference Hall-Taunus

Keynote ForumIntroductionTitle: The Impact of Salvia hispanica l. enhanced nutrition on breast cancer preventionPeter Onneken, Institute of Diet and Health, Germany

Networking and Refreshments Break @ FoyerTitle: Therapeutic effects of trehalose liposomes against breast tumors along with ApoptosisMatsumoto Yoko, Japan Nanomedicine Society , JapanSessions: Surgery Choices for Breast Cancer | Screening, Detecting and Diagnosing | Breast Cancer Breast Cancer Therpy , Prevention and MedicineSession Chair: Peter Onneken, Institute of Diet and Health, GermanySession Co-Chair: Peter Sandbichler, St.Vinzenz, AustriaTitle: A predictive model to identify who would benefit from primary tumor surgery among patients with metastatic breast cancer at diagnosis: a population-based analysisLingxiao Zhang, Xi’an Jiaotong University, ChinaTitle: Immediate breast reconstruction with laparoscopic harvested omental flap after breast cancer surgeryPeter Sandbichler, Department of surgery, Hospital St.Vinzenz, Austria

Lunch Break @ Rastaurant palate friendTitle: Breast cancer: Correlation of ultrasonographic features with molecular subtypeMaria Inês Branco, Centro Hospitalar Vila Nova de Gaia/Espinho, PortugalTitle: PITX2 DNA-methylation, a Novel Validated Predictive Marker In High-Risk Breast Cancer Patients to Assess the Benefit of Anthracycline-Based Chemotherapy Olaf G. Wilhelm, Therawis Pharma GmbH, GermanyTitle: Role of mammary gland stem/progenitor cells in tumorigenesisLuZhe Sun, University of Texas Health Science Center, USATitle: Preoperative ultrasound guided biopsy of axillary nodes for staging in patients with clinically negative axilla – in a tertiary care center in a third world countryImrana Masroor, Aga Khan University Hospital Karachi, PakistanTitle: Expression of ganglioside GD2, as a novel cancer stem cell marker in breast carcinomas.Maryam Mansoori, Iran University of Medical Sciences, Iran

Networking & Refreshments Break @ Foyer Poster Presentations @ Foyer

WCBC 001Title: Natural killer cell functionality is impaired by diet-induced obesity in a postmenopausal breast cancer mouse modelJulia Spielmann, Martin Luther University Halle-Wittenberg, Germany

WCBC 002Title: A case report of cerebral venous thrombosis after taking tamoxifen in breast cancer patientKitwadee Saksornchai Athigakunagorn, King Chulalongkorn Memorial Hospital, Thailand

WCBC 003Title: PIM1: A promising target in patients with triple negative breast cancerZhao Wen, Xi’an Jiaotong University, China

WCBC 004Title: Effects of Paeonia lactiflora on the Hs00 gene expression in triple negative breast cancer cellsJou-An Chen, National Yang-Ming University, Taiwan

Panel Discussion Award Ceremony

conferenceseries.com

UK: Conference Series llc LTD47 Churchfield Road, London, W3 6AY

Toll Free: +0-800-014-8923

June 15-17, 2017 London, UK

5th World Congress on

Breast Cancer

Scientific Program977th Conference

RegistrationsDay 1 June 15, 2017

Keynote ForumIntroductionTitle: Role of sphingosine-1-phosphate in estrogen receptor signaling in breast cancerSarah Spiegel, Virginia Commonwealth University School of Medicine, USATitle: Biomarkers that have prognostic and therapeutic importance for inflammatory breast cancer Yun Gong, University of Texas-M D Anderson Cancer Center, USA

Group Photo & Networking & Refreshments Break @ Foyer Sessions: Breast Cancer Therapy, Prevention and Management | Breast Cancer-Present Perspective | Breast Cancer NursingSession Chair: Steven M Hill, Tulane University School of Medicine, USASession Co-chair: Manjeet Rao, University of Texas Health Science Center, USA

Session IntroductionTitle: FOXK2 aberration in breast cancersAmy Hong Zhang, University of Texas-M D Anderson Cancer Center, USATitle: Circadian/melatonin disruption by dim light at night drives human epithelial breast cancer to a metastatic phenotypeSteven M Hill, Tulane University School of Medicine, USATitle: The impact of Nolvadex to generic tamoxifen switch on side effects and patient compliance in hormone receptor positive breast cancer patientsBashar Zeidan, Royal Hampshire County Hospital, UKTitle: Adverse effects of non-hormonal pharmacological interventions in breast cancer survivors, suffering from hot flashes: A systematic review and meta-analysisJill Brook Hervik, Vestfold Hospital Trust, NorwayTitle: Volkmann’s breast operation (modified radical mastectomy) and its value in modern treatment of breast cancer Valerijus Ostapenko, National Cancer Institute, Lithuania

Lunch Break @ RestaurantTitle: Exhibitor presentation By Sophiagenetics SAGerald Martin, Sophiagenetics SA, SwitzerlandTitle: The use of high dose estrogens for the treatment of breast cancerCarole Verhoeven, Pantarhei Oncology BV, The NetherlandsTitle: Exclusive self-destruction of triple negative breast cancer cellsCohen-Armon, Tel-Aviv University, IsraelTitle: A functional cross-talk between GPER and IGF1/IGF1R signaling drives breast tumor angiogenesis via activation of the HIF-1α/VEGF transduction pathway Ernestina Marianna De Francesco, University of Manchester, UK

Networking & Refreshments Break @ FoyerTitle: FoxM1 inhibition: A novel therapeutic avenue to treat breast cancers Manjeet Rao, University of Texas Health Science Center, USATitle: The effect of Internet-based breast cancer patient’s pathway on breast cancer patients’ empowering processAnne Ryhanen, The University of Turku, FinlandTitle: Relationships among body mass index, systemic immune-inflammation index and luminal subtype in the resistance to endocrine therapy of breast cancerQingxia Li, Hebei General Hospital, China

Panel Discussions

Opening Ceremonyconferenceseries.com

Conference Hall- Waterfront 1

Day 2 June 16, 2017Conference Hall- Waterfront 1

Keynote ForumTitle: Endocrine treatment of breast cancer: Current concepts to predict and prevent relapseHiltrud Brauch, Dr. Margarete Fischer-Bosch-Institute of Clinical Pharmacology, GermanyTitle: Naturopathic doctor in complementary natural treatment and prevention of cancerLloyd Jenkins, Budwig Center, SpainSessions: Screening, Detecting, and Diagnosing Breast Cancer | Surgery Choices for Breast Cancer | Personalized Medicine for Breast Cancer TreatmentSession Chair: Uhi Toh, Kurume University School of Medicine, JapanSession Co-chair: Anne Ryhanen, The University of Turku, Finland

Session IntroductionTitle: Comparison of bilateral whole-breast ultrasonography versus magnetic resonance imaging in the setting of breast cancer stagingHongying He, University of Texas Health Science Center at Houston, USA

Networking & Refreshments Break @ FoyerTitle: Oncoplastic and reconstructive surgery single institution experienceZhygulin Andrii, LISOD Israeli Cancer Care Hospital, UkrainTitle: Real-time indocyanine green (ICG) fluorescence imaging technique for the detection of SLNs in early-stage breast cancerUhi Toh, Kurume University School of Medicine, JapanTitle: Proteomic profiling of plasma and tissue proteins associated to mammographic breast density using the KARMA cohortMarike Gabrielson, Karolinska Institutet, SwedenTitle: Breast cancer in young women-Retrospective studyJana Slobodnikova, Alexander Dubcek University of Trencin, SlovakiaTitle: E-MPBC-imaging findings of a rare aggressive breast cancer subtype: Metaplastic carcinoma of the breastHale Aydin, Dr Abdurrahman Yurtaslan Ankara Oncology Training and Research Hospital, Turkey

Lunch Break @ RestaurantYoung Researchers Forum

Title: Enhancement of radiosensitivity of human endothelial and breast cancer cells with melatonin by regulating angiogenesis and genes involved in estrogen biosynthesisAlicia González González, University of Cantabria, SpainTitle: Breast density in Chinese women: Using percentage and area measures from a quantitative techniqueTong Li, The University of Sydney, AustraliaTitle: Oncogenic protein kinase D regulating networks in invasive breast cancerYan Liu, Southeast University, ChinaTitle: Evaluation of diffusion weighted MR Imaging and 18F-FDG PET for monitoring triple negative breast cancer response to Cisplatin treatmentNguyen Thu Huong, Gunma University Graduate School of Medicine, Japan

Networking & Refreshments Break @ FoyerPoster Presentation @ Foyer

WCBC 001Title: Assessment of Breast Cancer occurrence among females at King Abdul Aziz Hospital, Al-Ahsa: A retrospective study from 2007-2014Eman M.G. Hassan, Cairo University, Egypt

WCBC 002Title: Radial scare- The Compar of Ultrasound Breast Imaging with Histopathology Slobodníková Jana, Alexander Dubček University in Trenčín, Slovakia

WCBC 003Title: Inhibition of the orphan nuclear receptor estrogen related receptor alpha sensitizes breast cancer cells to DNMT inhibitorsMathieu Vernier, McGill University, Canada

WCBC 004Title: Exploring the effects of an exercise programme on women with breast cancerRuth McCrea, St Margaret’s Hospital, United Kingdom

WCBC 005Title: Problems of mammary prosthesis inserted for a long period Shintaro Asai, Nagoya Kyoritsu Hospital, Japan

Panel Discussion and Award Ceremony Day 3 June 17, 2017

Extended Networking & Lunch @ Restaurant

Bookmark your dates

E: breastcancer@conferenceseries.netwww.breastcancer.conferenceseries.com/

May 10-11, 2018 Frankfurt, Germany

10th World Congress on

Breast Cancer

th World Congress on Breast Cancer · Breast-Sparing Surgery Symptoms of Breast Cancer in Men...

Documents

Transcript of th World Congress on Breast Cancer · Breast-Sparing Surgery Symptoms of Breast Cancer in Men...